NEW YORK (GenomeWeb News) – Millennium Laboratories said today that it has acquired healthcare predictive analytics and decision support firm RxAnte.

RxAnte, a venture-backed startup, markets products to help health plans, pharmacy-benefit management companies, pharmacy chains, and healthcare providers improve patient adherence to treatments. Millennium, meanwhile, offers pharmacogenetic testing for pain treatment, substance abuse disorders, psychiatric conditions, and various chronic diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.